SCHOTT Pharma AG & Co. KGaA, DE000A3ENQ51

SCHOTT Pharma AG & Co. KGaA: Reinhard Mayer, buy

12.02.2026 - 16:19:07

SCHOTT Pharma AG & Co. KGaA / DE000A3ENQ51


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

12.02.2026 / 16:17 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Reinhard
Last name(s): Mayer

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
SCHOTT Pharma AG & Co. KGaA

b) LEI
529900TU48UE99NHEY88 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A3ENQ51

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
15.1000 EUR 45,300.00 EUR
15.3000 EUR 4,146.30 EUR
15.3000 EUR 1,208.70 EUR

d) Aggregated information
Price Aggregated volume
15.1209 EUR 50,655.0000 EUR

e) Date of the transaction
12/02/2026; UTC+1

f) Place of the transaction
Name: Xetra
MIC: XETR


12.02.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany
Internet: https://ir.schott-pharma.com/

 
End of News EQS News Service
103220  12.02.2026 CET/CEST @ dgap.de | DE000A3ENQ51 SCHOTT PHARMA AG & CO. KGAA